Nifedipine–pyrazine (2/1)

In the title compound, 2C(17)H(18)N(2)O(6)·C(4)H(4)N(2) [systematic name: 3,5-dimethyl 2,6-dimethyl-4-(2-nitro­phen­yl)-1,4-di­hydro­pyridine-3,5-dicarboxyl­ate–pyrazine (2/1)], the complete pyrazine molecule is generated by crystallographic inversion symmetry. The center of the pyrazine ring lies o...

Descripción completa

Detalles Bibliográficos
Autores principales: Schultheiss, Nate, Roe, Melanie, Smit, Jared P.
Formato: Texto
Lenguaje:English
Publicado: International Union of Crystallography 2010
Materias:
Organic Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3008143/
https://www.ncbi.nlm.nih.gov/pubmed/21588649
http://dx.doi.org/10.1107/S1600536810031703
Descripción
Sumario:In the title compound, 2C(17)H(18)N(2)O(6)·C(4)H(4)N(2) [systematic name: 3,5-dimethyl 2,6-dimethyl-4-(2-nitro­phen­yl)-1,4-di­hydro­pyridine-3,5-dicarboxyl­ate–pyrazine (2/1)], the complete pyrazine molecule is generated by crystallographic inversion symmetry. The center of the pyrazine ring lies on an inversion center. The nifedipine mol­ecules are linked into chains along the c axis through N—H⋯O hydrogen bonds, while the pyrazine mol­ecules are organized in the structure through van der Waals inter­actions.

Ejemplares similares